EP3371200 - TRIGGER-ACTIVATABLE METABOLIC SUGAR PRECURSORS FOR CANCER-SELECTIVE LABELING AND TARGETING [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 13.05.2022 Database last updated on 13.11.2024 | |
Former | Request for examination was made Status updated on 10.08.2018 | ||
Former | The international publication has been made Status updated on 18.04.2017 | Most recent event Tooltip | 28.10.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states The Board of Trustees of the University of Illinois 352 Henry Administration Building 506 South Wright Street Urbana, IL 61801 / US | [2018/37] | Inventor(s) | 01 /
CHENG, Jianjun 2304 Lynwood Drive Champaign, IL 61821 / US | 02 /
WANG, Hua 38 Craigie Street Apt 2 Somerville, MA 02143 / US | [2018/37] | Representative(s) | HGF HGF Limited 1 City Walk Leeds LS11 9DX / GB | [N/P] |
Former [2018/37] | HGF Limited 1 City Walk Leeds LS11 9DX / GB | Application number, filing date | 16854444.3 | 07.10.2016 | [2018/37] | WO2016US56046 | Priority number, date | US201562238326P | 07.10.2015 Original published format: US 201562238326 P | [2018/37] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017062800 | Date: | 13.04.2017 | Language: | EN | [2017/15] | Type: | A1 Application with search report | No.: | EP3371200 | Date: | 12.09.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 13.04.2017 takes the place of the publication of the European patent application. | [2018/37] | Search report(s) | International search report - published on: | US | 13.04.2017 | (Supplementary) European search report - dispatched on: | EP | 31.03.2020 | Classification | IPC: | C07H15/18, C07H15/26, A61K31/7034, A61K31/7042, A61P35/00 | [2020/04] | CPC: |
C07H15/26 (EP,KR,US);
C07H15/18 (EP,KR,US);
A61K47/552 (US);
A61P35/00 (EP,KR,US);
G01N33/57492 (US)
|
Former IPC [2018/37] | C07H15/00, A61K31/7034, A61K31/7042 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/37] | Title | German: | ÜBER TRIGGER AKTIVIERBARE METABOLISCHE ZUCKERVORLÄUFER FÜR KREBSSELEKTIVE MARKIERUNG UND ABZIELUNG | [2018/37] | English: | TRIGGER-ACTIVATABLE METABOLIC SUGAR PRECURSORS FOR CANCER-SELECTIVE LABELING AND TARGETING | [2018/37] | French: | PRÉCURSEURS MÉTABOLIQUES DE SUCRE, ACTIVABLES PAR UN DÉCLENCHEUR POUR LE MARQUAGE ET LE CIBLAGE SÉLECTIF D'UN CANCER | [2018/37] | Entry into regional phase | 26.04.2018 | National basic fee paid | 26.04.2018 | Search fee paid | 26.04.2018 | Designation fee(s) paid | 26.04.2018 | Examination fee paid | Examination procedure | 26.04.2018 | Examination requested [2018/37] | 26.04.2018 | Date on which the examining division has become responsible | 21.10.2020 | Amendment by applicant (claims and/or description) | 13.05.2022 | Despatch of a communication from the examining division (Time limit: M04) | 02.09.2022 | Reply to a communication from the examining division | 07.08.2024 | Despatch of a communication from the examining division (Time limit: M04) | Fees paid | Renewal fee | 29.10.2018 | Renewal fee patent year 03 | 28.10.2019 | Renewal fee patent year 04 | 27.10.2020 | Renewal fee patent year 05 | 27.10.2021 | Renewal fee patent year 06 | 27.10.2022 | Renewal fee patent year 07 | 27.10.2023 | Renewal fee patent year 08 | 28.10.2024 | Renewal fee patent year 09 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2014065661 (SYNAFFIX BV [NL]); | International search | [Y]US2008132458 (MATTEUCCI MARK [US], et al) [Y] 6, 7 * para [0026] *; | [A]US2010160299 (BAKER JR JAMES R [US], et al) [A] 37-40, 42-43, 62* Figure 3; Figure 16 *; | [YA]US2014010763 (SHABAT DORON [IL], et al) [Y] 1-18 * para [0022]-[0029]:[0292]-[0294]; Figures 25, 27 and 29c * [A] 20-23, 34-40, 42, 43, 62; | [YA]US2014031535 (JEFFREY SCOTT [US]) [Y] 1-18 * para [0012];[0016];[0021]-[0031]:[0133];[0134][0329]:[0330]:[0366]:[0376]:[0378]:[0379]:[0380];[0700];[0718];[0719] * [A] 20-23, 34-40, 42, 43, 62; | [YA]US2014046051 (VRASIDAS IOANNIS [GR], et al) [Y] 1-18 * para [0092];[0106];[0119] * [A] 20-23, 34-36; | [Y] - AMSBERRY et al., "Amine Prodrugs Which Utilize Hydroxy Amide Lactonization. 1.", A Potential Redox-Sensitive Amide Prodrug in Pharmaceutical Research, (19910000), vol. 8, pages 323 - 330, XP000609337 [Y] 11-13 * . pg 323, Col 2, para 1 to pg 324, Col 1, para 1, Figure 1; pg 329, Col 1, para 2; Col 2, para 1 * DOI: http://dx.doi.org/10.1023/A:1015885213625 | Examination | WO2014202775 |